TY  - GEN
AU  - Arribas López,José R
TI  - [Secondary effects of treatment with maraviroc and other CCR5 antagonists. Potential impact of the CCR5 blocker]
SN  - 0213-005X
PY  - 2009///0508
KW  - Adult
KW  - Benzoates
KW  - adverse effects
KW  - CCR5 Receptor Antagonists
KW  - Chemical and Drug Induced Liver Injury
KW  - etiology
KW  - Clinical Trials as Topic
KW  - statistics & numerical data
KW  - Comorbidity
KW  - Cyclohexanes
KW  - Diketopiperazines
KW  - Disease Susceptibility
KW  - Drug Design
KW  - HIV Fusion Inhibitors
KW  - HIV Infections
KW  - drug therapy
KW  - Homozygote
KW  - Humans
KW  - Hyperlipidemias
KW  - epidemiology
KW  - Incidence
KW  - Infections
KW  - Maraviroc
KW  - Membrane Fusion
KW  - drug effects
KW  - Neoplasms
KW  - Piperazines
KW  - Receptors, CCR5
KW  - genetics
KW  - Sequence Deletion
KW  - Spiro Compounds
KW  - Triazoles
KW  - Virus Attachment
KW  - Virus Internalization
KW  - env Gene Products, Human Immunodeficiency Virus
KW  - physiology
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1016/s0213-005x(08)76560-1
ER  -